|3.||Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
|1.||Akin, Cem: 2 articles (04/2013 - 08/2003)|
|2.||Ryan, Russell J H: 1 article (04/2013)|
|3.||Hornick, Jason L: 1 article (04/2013)|
|4.||Wills, Marcia: 1 article (04/2013)|
|5.||Selig, Martin K: 1 article (04/2013)|
|6.||Ferry, Judith A: 1 article (04/2013)|
|7.||Nielsen, G Petur: 1 article (04/2013)|
|8.||Castells, Mariana: 1 article (04/2013)|
|9.||Xu, Xia: 1 article (11/2011)|
|10.||Liu, Wei Ping: 1 article (11/2011)|
|1.||imatinib (Gleevec)FDA Link
04/01/2013 - "Molecular testing of mast cell sarcoma has not thus far detected the imatinib-resistant KIT D816V mutation, suggesting that recognition of these cases may facilitate specific targeted therapy."
11/01/2011 - "Our results indicate that imatinib is of potential use in the treatment of mast cell sarcoma."
11/01/2011 - "Successful treatment of mast cell sarcoma of the uterus with imatinib."
11/01/2011 - "We report successful treatment of uterine mast cell sarcoma with imatinib in a 39-year-old woman who presented with abdominal distention and massive ascites. "
|2.||Stem Cell FactorIBA
08/01/2003 - "Two novel stem cell factor (SCF) dependent human mast cell lines, designated LAD 1 and 2, were established from bone marrow aspirates from a patient with mast cell sarcoma/leukemia. "
08/01/2003 - "Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI."
03/01/1994 - "The following total tumors (benign plus malignant) occurred in control dogs but not in radium dogs: brain = 3, peritoneum = 1, and pituitary = 4. Malignant tumors other than leukemia appearing in control animals and not among radium dogs were brain = 2, lymph nodes = 1, adrenal = 3, uterus = 1, and pancreas = 5. Tumors that occurred in dogs given radium and not in controls were 3 mast cell sarcomas and 2 tumors of the thymus (1 malignant). "
12/15/1988 - "A large infiltrating mast cell sarcoma in a dog, which had been refractory before surgical excision, was controlled 2 months after completion of a combined radiotherapy and hyperthermia regimen. "
12/15/1988 - "Use of hyperthermia and radiotherapy in treatment of a large mast cell sarcoma in a dog."
|2.||Combination Drug Therapy (Combination Chemotherapy)
|3.||Drug Therapy (Chemotherapy)